Alunbrig 90mg (brigatinib)30 Brand Name : Briganix
Composition : Brigatinib 90mg
Manufactured by : Beacon Pharmaceuticals
Form : Tablet
Packing : Pack of 30 Tablets
Alunbrig 90mg 98.4 Pharmacy advice for Briganix 90mg 30 Tablets
- Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
- Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
- Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
- May cause visual disturbances; advise patients to report any visual symptoms.
- Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
- Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
- May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize antihyperglycemic medications as needed.
- Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
- Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
- Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
- May cause visual disturbances; advise patients to report any visual symptoms.
- Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
- Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
- May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize antihyperglycemic medications as needed.
Alunbrig 90mg
Reviews
There are no reviews yet.